CR6308A - PHARMACEUTICAL AGENTS FOR THE TREATMENT OF PARKINSON, ADHD AND MICROADENOMAS DISEASE - Google Patents

PHARMACEUTICAL AGENTS FOR THE TREATMENT OF PARKINSON, ADHD AND MICROADENOMAS DISEASE

Info

Publication number
CR6308A
CR6308A CR6308A CR6308A CR6308A CR 6308 A CR6308 A CR 6308A CR 6308 A CR6308 A CR 6308A CR 6308 A CR6308 A CR 6308A CR 6308 A CR6308 A CR 6308A
Authority
CR
Costa Rica
Prior art keywords
microadenomas
parkinson
disease
treatment
adhd
Prior art date
Application number
CR6308A
Other languages
Spanish (es)
Inventor
Rose Jackson Elisa
Mc Lean Stafford
Howard Zorn Stevin
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Priority to CR6308A priority Critical patent/CR6308A/en
Publication of CR6308A publication Critical patent/CR6308A/en

Links

Landscapes

  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se refiere al uso de ciertos derivados de pirido (1,2-a) - pirazina, también descritos como compuestos bis- azabicíclicos y definidos por la fórmula (I), en el tratamiento de la enfermedad de Parkinson, el trastorno de hiperactividad con déficit de atención y microadenomas en mamíferos y a composiciones relacionadasIt refers to the use of certain derivatives of pyrido (1,2-a) -pyrazine, also described as bis-azabicyclic compounds and defined by formula (I), in the treatment of Parkinson's disease, deficit hyperactivity disorder of attention and microadenomas in mammals and related compositions

CR6308A 2001-02-14 2001-02-14 PHARMACEUTICAL AGENTS FOR THE TREATMENT OF PARKINSON, ADHD AND MICROADENOMAS DISEASE CR6308A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CR6308A CR6308A (en) 2001-02-14 2001-02-14 PHARMACEUTICAL AGENTS FOR THE TREATMENT OF PARKINSON, ADHD AND MICROADENOMAS DISEASE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CR6308A CR6308A (en) 2001-02-14 2001-02-14 PHARMACEUTICAL AGENTS FOR THE TREATMENT OF PARKINSON, ADHD AND MICROADENOMAS DISEASE

Publications (1)

Publication Number Publication Date
CR6308A true CR6308A (en) 2004-02-23

Family

ID=51359472

Family Applications (1)

Application Number Title Priority Date Filing Date
CR6308A CR6308A (en) 2001-02-14 2001-02-14 PHARMACEUTICAL AGENTS FOR THE TREATMENT OF PARKINSON, ADHD AND MICROADENOMAS DISEASE

Country Status (1)

Country Link
CR (1) CR6308A (en)
  • 2001

Similar Documents

Publication Publication Date Title
AR029739A1 (en) PHARMACEUTICAL AGENTS FOR THE TREATMENT OF PARKINSON, ADHD AND MICROADENOMAS DISEASE
MY135902A (en) SUBSTITUTED HEXAHYDROPYRAZINO [1, 2-a] PYRIMIDINE-4, 7-DIONE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS
NO20054208L (en) Nitrogen-substituted hexahydropyrazino [1,2-a] pyrimidine-4,7-dione derivatives, methods of preparation and use thereof as medicaments
UY28510A1 (en) CHEMICAL COMPOUNDS
ECSP066391A (en) [1,8] NAFTIRIDIN-2-ONAS AND RELATED COMPOUNDS FOR THE TREATMENT OF CHICHOPHRENIA
UY28150A1 (en) THERAPEUTIC AGENTS
PA8593001A1 (en) PIRIMIDINE DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELLULAR GROWTH
CR6726A (en) AZAPOLICICLIC COMPOUNDS CONDENSED WITH ARILO
CY1113323T1 (en) [3,4-D] DIOXOLANIUM COMPOUNDS FOR USE IN THE TREATMENT OF VIRUS INFECTIONS AND CANCER
BRPI0509369A (en) azaindoles useful as inhibitors of jak and other protein kinases
BRPI0413022A (en) chromed 3-amino and 2-amino tetraline derivatives
BRPI0606318A2 (en) compound, composition, and use of a compound
ECSP088297A (en) 7- [2- [4- (6-FLUORO-3-METIL-1,2-BENCISOXAZOL-5-IL) -1-PIPERAZINIL] ETIL] -2- (1-PROPINYL) -7H-PIRAZOL- [4, 3-e] - [1,2,4] -TRIAZOL- [1,5-C] -PIRIMIDIN-5-AMINA
UY28376A1 (en) THERAPEUTIC AGENTS
UY28144A1 (en) THERAPEUTIC AGENTS
CY1110316T1 (en) USE OF PIPAMERONIS AND AN SNDRI, SNRI Ή SSRI FOR MENTAL DISORDERS OR ANXIETY TREATMENT
SE0400043D0 (en) New compounds
SE0403171D0 (en) New compounds
ECSP055964A (en) HETEROCICLIL-3-SULPHONYLINDAZOLS AS LIGANDS OF 5-HYDROXYTHYRIPTAMINE-6
ECSP088250A (en) DERIVATIVES OF PIRAZOL AS THERAPEUTIC AGENTS
UY28377A1 (en) THERAPEUTIC AGENTS
ES2340502T3 (en) COMPOUNDS OF 1,4,8-TRIAZAESPIRO (4,5) DECAN-2-ONA SUBSTITUTED FOR THE TREATMENT OF OBESITY.
ECSP044971A (en) ISOXAZOLOPIRIDINONAS AND ITS USE IN PARKINSON'S DISEASE TREATMENT
DE502006004182D1 (en) SUBSTITUTED 5,6,7,8-TETRAHYDRO-IMIDAZOÄ1, 2-ATPYRIDINE-2-YLAMINE COMPOUNDS AND THEIR USE FOR THE PREPARATION OF MEDICAMENTS
BRPI0513287A (en) pyrido pyrimidine derivatives, their preparation, their application in therapeutic

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)